Halozyme Therapeutics
HALO
#2125
Rank
C$10.53 B
Marketcap
$85.56
Share price
2.51%
Change (1 day)
58.82%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): C$0.77 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are C$1.01 Billion. , an increase over its 2023 earnings that were of C$0.50 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 C$0.80 B59.94%
2023 C$0.50 B39.94%
2022 C$0.36 B0.16%
2021 C$0.35 B92.2%
2020 C$0.18 B-278.96%
2019 -C$0.11 Billion-9.45%
2018 -C$0.12 Billion-229.51%
2017 C$89.11 M-160.48%
2016 -C$0.15 Billion216.03%
2015 -C$46.63 Million-52.86%
2014 -C$98.91 Million-18.09%
2013 -C$0.13 Billion55.88%
2012 -C$77.47 Million169.94%
2011 -C$28.7 Million-63.44%
2010 -C$78.49 Million-7.19%
2009 -C$84.56 Million15.91%
2008 -C$72.96 Million83.89%
2007 -C$39.68 Million78.1%
2006 -C$22.28 Million16%
2005 -C$19.21 Million45.24%
2004 -C$13.23 Million682.42%
2003 -C$1.69 Million1659.12%
2002 -C$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$36.21 M-95.51%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.34 B 2,176.01%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.24 B-70.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.04 B 1,146.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.48 B 1,325.52%๐Ÿ‡ซ๐Ÿ‡ท France
C$25.22 B 3,030.68%๐Ÿ‡บ๐Ÿ‡ธ USA